279 related articles for article (PubMed ID: 26083985)
21. Thromboembolic events are associated with prolonged clot lysis time in patients with permanent atrial fibrillation.
Ząbczyk M; Majewski J; Lelakowski J
Pol Arch Med Wewn; 2011 Nov; 121(11):400-7. PubMed ID: 22064373
[TBL] [Abstract][Full Text] [Related]
22. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
Morishima Y; Honda Y
J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
[TBL] [Abstract][Full Text] [Related]
23. Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk.
Gajos G; Konieczynska M; Zalewski J; Undas A
Cardiovasc Diabetol; 2015 May; 14():44. PubMed ID: 25928628
[TBL] [Abstract][Full Text] [Related]
24. Reduced plasma fibrin clot permeability and susceptibility to lysis in patients with inflammatory bowel disease: a novel prothrombotic mechanism.
Owczarek D; Cibor D; Sałapa K; Głowacki MK; Mach T; Undas A
Inflamm Bowel Dis; 2013 Nov; 19(12):2616-24. PubMed ID: 24108112
[TBL] [Abstract][Full Text] [Related]
25. Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study.
Polak MW; Siudut J; Plens K; Undas A
J Thromb Thrombolysis; 2019 Nov; 48(4):603-609. PubMed ID: 31432450
[TBL] [Abstract][Full Text] [Related]
26. Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndrome.
Asztabski M; Wypasek E; Ząbczyk M; Undas A
Thromb Res; 2014 Nov; 134(5):945-51. PubMed ID: 25194881
[TBL] [Abstract][Full Text] [Related]
27. Acute CO poisoning is associated with impaired fibrinolysis and increased thrombin generation.
Gawlikowski T; Gomolka E; Piekoszewski W; Jawień W; Undas A
Basic Clin Pharmacol Toxicol; 2013 May; 112(5):352-6. PubMed ID: 23228150
[TBL] [Abstract][Full Text] [Related]
28. Lysability of fibrin clots is a potential new determinant of stroke risk in atrial fibrillation.
Skov J; Sidelmann JJ; Bladbjerg EM; Jespersen J; Gram J
Thromb Res; 2014 Sep; 134(3):717-22. PubMed ID: 25042725
[TBL] [Abstract][Full Text] [Related]
29. A new insight into retinal vein occlusion pathogenesis.
Karska-Basta I; Kubicka-Trzaska A; Pogrzebielski A; Romanowska-Dixon B
Klin Oczna; 2013; 115(4):269-74. PubMed ID: 24908915
[TBL] [Abstract][Full Text] [Related]
30. Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
Taketomi T; Szlam F; Bader SO; Sheppard CA; Levy JH; Tanaka KA
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):135-41. PubMed ID: 18277134
[TBL] [Abstract][Full Text] [Related]
31. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
Kwasny-Krochin B; Gluszko P; Undas A
Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
[TBL] [Abstract][Full Text] [Related]
32. Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism.
Palka I; Nessler J; Nessler B; Piwowarska W; Tracz W; Undas A
Heart; 2010 Jul; 96(14):1114-8. PubMed ID: 20610458
[TBL] [Abstract][Full Text] [Related]
33. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
34. Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma.
Carr ME; Dent RM; Carr SL
J Lab Clin Med; 1996 Jul; 128(1):83-8. PubMed ID: 8759939
[TBL] [Abstract][Full Text] [Related]
35. Unfavorably altered plasma clot properties in women with a HERDOO2 score equal to or greater than 2 and prediction of recurrent venous thromboembolism.
Mrozińska S; Cieślik J; Broniatowska E; Undas A
Pol Arch Intern Med; 2018 Oct; 128(10):572-579. PubMed ID: 30113019
[TBL] [Abstract][Full Text] [Related]
36. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
[TBL] [Abstract][Full Text] [Related]
37. A prothrombotic state and denser clot formation in patients following acute limb ischemia of unknown cause.
Karpińska IA; Nowakowski T; Wypasek E; Plens K; Undas A
Thromb Res; 2020 Mar; 187():32-38. PubMed ID: 31951936
[TBL] [Abstract][Full Text] [Related]
38. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.
Undas A; Kaczmarek P; Sladek K; Stepien E; Skucha W; Rzeszutko M; Gorkiewicz-Kot I; Tracz W
Thromb Haemost; 2009 Dec; 102(6):1176-82. PubMed ID: 19967149
[TBL] [Abstract][Full Text] [Related]
39. Altered plasma fibrin clot properties are associated with in-stent thrombosis.
Undas A; Zalewski J; Krochin M; Siudak Z; Sadowski M; Pregowski J; Dudek D; Janion M; Witkowski A; Zmudka K
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):276-82. PubMed ID: 19910643
[TBL] [Abstract][Full Text] [Related]
40. Reduced plasma fibrin clot permeability is associated with recurrent thromboembolic events in patients with antiphospholipid syndrome.
Celinska-Löwenhoff M; Zabczyk M; Iwaniec T; Plens K; Musial J; Undas A
Rheumatology (Oxford); 2018 Aug; 57(8):1340-1349. PubMed ID: 29672756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
